Articles

ORIGINAL ARTICLE

Nanomechanical‐based classification of prostate tumor using atomic force microscopy

Jinshu Zeng MSc, Yan Zhang BS, Renfeng Xu BS, Huitin Chen BS, Xiaoqiong Tang PhD, Sheng Zhang MSc, Hongqin Yang PhD, 
  •  27 September 2023
ORIGINAL ARTICLE

Development and internal validation of a nomogram predicting significant prostate cancer: Is it clinically applicable in low prevalent prostate cancer countries? A multicenter study

Mostafa A. Arafa PhD, Karim H. Farhat PhD, Farrukh K. Khan MD, Danny M. Rabah PhD, Hala Elmorshedy PhD, Alaa Mokhtar PhD, Waleed Al-Taweel PhD, 
  •  27 September 2023
ORIGINAL ARTICLE

Polyphyllin I induces ferroptosis in castration‐resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis

Peiliang Zou MM, Zheng Chen MD, Qixiong He BD, Yumin Zhuo MM, 
  •  26 September 2023
ORIGINAL ARTICLE
Open access

The diagnostic accuracy of 68Ga-PSMA-PET/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: A single-center cohort analysis

Pawel Rajwa MD, Julian Heidenreich, Alexander Drzezga, Matthias Schmidt, Shahrokh F. Shariat, Axel Heidenreich, 
  •  26 September 2023
REVIEW ARTICLE

The association between beta‐blockers use and prostate cancer mortality: A mini systematic review and meta‐analysis

Alessandro Uleri MD, Michael Baboudjian MD, Alessandro Tedde MD, Pawel Rajwa MD, Benjamin Pradere MD, Andrea Gallioli MD, Alberto Breda PhD, Guillaume Ploussard PhD, 
  •  14 September 2023
More articles

The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.

Distribution of metastatic sites in patients with prostate cancer: A population‐based analysis

Giorgio Gandaglia, Firas Abdollah, Jonas Schiffmann, Vincent Trudeau, Shahrokh F. Shariat, Simon P. Kim, Paul Perrotte, Francesco Montorsi, Alberto Briganti, Quoc-Dien Trinh, Pierre I. Karakiewicz, Maxine Sun, 
  •  210-216
  •  16 October 2013

PC3 is a cell line characteristic of prostatic small cell carcinoma

Sheng Tai, Yin Sun, Jill M. Squires, Hong Zhang, William K. Oh, Chao-Zhao Liang MD, PhD, Jiaoti Huang MD, PhD, 
  •  1668-1679
  •  22 March 2011

Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

Richard P. Junghans, Qiangzhong Ma, Ritesh Rathore, Erica M. Gomes, Anthony J. Bais, Agnes S.Y. Lo, Mehrdad Abedi, Robin A. Davies, Howard J. Cabral, A. Samer Al-Homsi, Stephen I. Cohen, 
  •  1257-1270
  •  21 June 2016
Open access

LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an­­d Serve as Models for Evaluating Cancer Therapeutics

Holly M. Nguyen, Robert L. Vessella, Colm Morrissey, Lisha G. Brown, Ilsa M. Coleman, Celestia S. Higano, Elahe A. Mostaghel, Xiaotun Zhang, Lawrence D. True, Hung-Ming Lam, Martine Roudier, Paul H. Lange, Peter S. Nelson, Eva Corey, 
  •  654-671
  •  3 February 2017
Open access

M2 macrophages and regulatory T cells in lethal prostate cancer

Ann Erlandsson, Jessica Carlsson, Marie Lundholm, Anna Fält, Sven-Olof Andersson, Ove Andrén, Sabina Davidsson, 
  •  363-369
  •  30 November 2018
More articles

Latest news

More news >

Recent issues